Whittier Trust Co. of Nevada Inc. Acquires 1,221 Shares of Kenvue Inc. (NYSE:KVUE)

Whittier Trust Co. of Nevada Inc. raised its holdings in Kenvue Inc. (NYSE:KVUE) by 40.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,219 shares of the company’s stock after purchasing an additional 1,221 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Kenvue were worth $90,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of Kenvue by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 148,880,588 shares of the company’s stock worth $3,205,399,000 after purchasing an additional 2,226,390 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Kenvue by 19.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 109,327,221 shares of the company’s stock valued at $2,353,816,000 after acquiring an additional 18,118,056 shares during the period. Wellington Management Group LLP grew its stake in Kenvue by 6.7% in the fourth quarter. Wellington Management Group LLP now owns 76,501,956 shares of the company’s stock valued at $1,647,087,000 after acquiring an additional 4,815,126 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Kenvue by 9.1% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 66,665,454 shares of the company’s stock valued at $1,435,307,000 after acquiring an additional 5,574,265 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Kenvue by 10.6% in the first quarter. Bank of New York Mellon Corp now owns 35,897,723 shares of the company’s stock valued at $770,365,000 after purchasing an additional 3,438,207 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on KVUE shares. Sanford C. Bernstein initiated coverage on Kenvue in a report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price target on the stock. HSBC boosted their price target on Kenvue from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. William Blair initiated coverage on Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Finally, Citigroup reaffirmed a “neutral” rating and issued a $21.00 target price on shares of Kenvue in a research report on Tuesday, May 28th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $23.09.

Kenvue Price Performance

Shares of KVUE traded down $0.03 during trading hours on Tuesday, reaching $18.22. 11,983,017 shares of the stock traded hands, compared to its average volume of 19,330,852. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market cap of $34.89 billion, a P/E ratio of 23.36, a price-to-earnings-growth ratio of 1.94 and a beta of 1.40. The company’s 50-day moving average price is $19.08 and its two-hundred day moving average price is $19.85. Kenvue Inc. has a 52-week low of $17.75 and a 52-week high of $25.61.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The firm had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $3.79 billion. The company’s revenue was down 24.9% compared to the same quarter last year. On average, analysts anticipate that Kenvue Inc. will post 1.17 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.39%. The ex-dividend date of this dividend was Tuesday, May 7th. Kenvue’s dividend payout ratio is currently 102.56%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.